James M. Thorburn, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 15,000 shares at $29.47 ($448K) on 2019-08-16, disclosed to the SEC on 2019-08-20.
Open-market sale of $448k TWST by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.47 | 3,000 | $88K | 19.7% |
| 2 | $29.51 | 1,000 | $30K | 6.6% |
| 3 | $29.51 | 1,000 | $30K | 6.6% |
| 4 | $29.58 | 1,000 | $30K | 6.6% |
| 5 | $29.58 | 1,000 | $30K | 6.6% |
| 6 | $29.60 | 1,500 |
| $44K |
| 9.9% |
| 7 | $30.14 | 500 | $15K | 3.4% |
| 8 | $30.14 | 500 | $15K | 3.4% |
| 9 | $30.25 | 500 | $15K | 3.4% |
| 10 | $30.31 | 500 | $15K | 3.4% |
| 11 | $30.31 | 500 | $15K | 3.4% |
| 12 | $30.40 | 1,000 | $30K | 6.8% |
| 13 | $30.40 | 1,000 | $30K | 6.8% |
| 14 | $30.45 | 250 | $8K | 1.7% |
| 15 | $30.45 | 250 | $8K | 1.7% |
| 16 | $30.46 | 250 | $8K | 1.7% |
| 17 | $30.46 | 250 | $8K | 1.7% |
| 18 | $30.47 | 500 | $15K | 3.4% |
| 19 | $30.47 | 500 | $15K | 3.4% |
| Total | $29.89 avg | 15,000 | $448K | 100% |
| Filing → |
| TWST | SELL | 2022-04-18 | $518K | — | Filing → |
| TWST | SELL | 2022-03-07 | $359K | — | Filing → |
| TWST | SELL | 2022-02-23 | $432K | — | Filing → |